XML 21 R7.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Cash flows from operating activities:      
Net income (loss) $ (37,091) $ (12,395) $ 58,975
Adjustments to reconcile net income (loss) to net cash provided by / (used in) operating activities:      
Bargain purchase gain, net of tax (6,914) 0 0
Depreciation and amortization 13,078 12,713 9,498
Net gain on sale of divested business 0 (15,638) 0
Amortization of Debt Issue Costs 1,261 1,208 1,163
Amortization of debt discount 7,435 6,885 6,302
Gain / (loss) on extinguishment of debt 10,551 0 0
Tax benefits (expense) from share based payment arrangements 0 (822) 3,806
Share-based compensation 28,443 26,039 21,740
Deferred tax benefit 45,856 (21,274) (17,966)
Deferred rent obligations (2,192) (880) (2,333)
Net loss (gain) on disposal of fixed assets (2,346) 0 54
Contingent liability adjustment 0 2,139 (200)
Purchases of securities owned, at fair value (4,943,394) (4,483,975) (5,856,112)
Proceeds from sales of securities owned, at fair value 5,131,938 4,447,094 6,039,719
Proceeds from sales of securities sold, not yet purchased, at fair value 2,455,876 3,016,934 2,730,939
Payments to cover securities sold, not yet purchased, at fair value (2,444,010) (3,054,869) (2,674,153)
Net (gains) losses on securities, derivatives and other investments (78,303) (28,878) (34,495)
Consolidated Funds      
Purchases of securities owned, at fair value (385,544) (113,653) (25,000)
Proceeds from sales of securities owned, at fair value 338,268 73,011 0
Proceeds from sales of securities sold, not yet purchased, at fair value 217 2,226 0
Payments to cover securities sold, not yet purchased, at fair value (899) (1,799) 0
Purchases of other investments (26,206) (221,897) (92,305)
Proceeds from sales of other investments 64,867 17,116 31,417
Net realized and unrealized (gains) losses on investments and other transactions (28,267) (17,402) (13,552)
(Increase) decrease in operating assets:      
Cash acquired through acquisition 30,562 0 0
Cash collateral pledged (4,546) (3,257) (1,779)
Segregated Cash 13,781 229 (1,253)
Securities owned, at fair value, held at broker dealer (102,137) (17,005) 14,877
Receivable on derivative contracts, at fair value (46,277) 16,717 10,259
Securities Borrowed (184,827) 0 676,100
Deposits with clearing organizations, brokers and banks (32,460) (1,874) (6,965)
Receivable from brokers, dealers and clearing organizations (366,297) 31,795 (20,785)
Receivable from customers, net of allowance (6,422) 0 0
Fees receivable, net of allowance (29,669) (12,632) 11,099
Due from related parties 4,815 (176) (13,344)
Other assets (33,454) (10,048) 4,580
Consolidated Funds      
Cash and cash equivalents (4,227) (3,827) (13,433)
Receivable on derivative contracts, at fair value (1,627) (893) 0
Receivable from brokers 334 (5,978) 0
Other assets 123 152 770
Increase (decrease) in operating liabilities:      
Securities sold, not yet purchased, at fair value, held at broker dealer 19,226 7,160 (11,747)
Payable for derivative contracts, at fair value (1,399) (421) (20,147)
Securities Loaned 170,472 0 (682,493)
Payable to brokers, dealers and clearing organizations (32,440) 78,520 (204,186)
Payables to customers 340,666 0 0
Commission management payable (15,857) 242 2,225
Compensation payable 9,150 (60,279) 5,540
Fees payable (639) (2,366) (693)
Due to related parties (3) 244 (145)
Accounts payable, accrued expenses and other liabilities 13,046 (9,133) (5,337)
Consolidated Funds      
Contributions received in advance (2,000) 1,150 850
Payable to brokers (2,949) 3,699 0
Payable for derivative contracts, at fair value 6,558 572 0
Due to related parties (189) 453 3
Accounts payable, accrued expenses and other liabilities (330) 528 (98)
Net cash provided by / (used in) operating activities (116,392) (354,545) (68,605)
Cash flows from investing activities:      
Purchases of other investments (10,419) (33,786) (14,149)
Purchase of business (55,049) (6,258) (38,416)
Proceeds from sales of other investments 71,749 54,068 58,166
Loans issued (13,745) 0 (46,000)
Proceeds from loans held for investments 3,203 42,800 0
Proceeds from divested business, net of cash divested 0 17,303 0
Purchase of fixed assets (5,986) (15,613) (7,030)
Sale of fixed assets 7,850 0 0
Net cash provided by / (used in) investing activities (2,397) 58,514 (47,429)
Cash flows from financing activities:      
Proceeds from Convertible Debt 135,000 0 0
Repayments on convertible debt (115,140) 0 0
Proceeds from Issuance of Preferred Stock, net of issuance costs 0 0 117,194
Capped call option transaction 0 0 (15,878)
Deferred Debt Issuance Costs (7,176) 0 0
Borrowings on notes and other debt 171,148 30,638 7,140
Repayments on notes and other debt (72,757) (29,800) (3,299)
Income tax effect from share-based payment arrangements 0 (822) 3,806
Proceeds from Stock Options Exercised 0 0 394
Purchase of treasury stock (19,662) (7,654) (48,678)
Cash paid to acquire net assets (contingent liability payment) (393) (2,358) (1,725)
Capital contributions to redeemable non-controlling interests in operating entities 0 10 5,644
Capital withdrawals to redeemable non-controlling interests in operating entities (5,178) (6,995) (13,860)
Consolidated Funds      
Capital contributions by redeemable non-controlling interests in Consolidated Funds 117,812 276,914 104,533
Capital withdrawals to redeemable non-controlling interests in Consolidated Funds (65,803) (10,144) (11,514)
Net cash provided by / (used in) financing activities 137,851 249,789 143,757
Change in cash and cash equivalents 19,062 (46,242) 27,723
Cash and cash equivalents at beginning of period 110,990 157,232 129,509
Cash and cash equivalents at end of period 130,052 110,990 157,232
Interest Paid 26,632 17,540 17,525
Income Taxes Paid 2,172 5,085 4,161
Supplemental information      
Conversion option value on 2022 Convertible Notes 23,387 0 0
Purchase of treasury stock, at cost, through net settlement (See Note 24) 11,889 8,835 8,907
Preferred stock dividends declared (See Note 24) 6,792 6,792 4,075
Net assets (liabilities) acquired upon acquisition (net of cash) (See Note 2) 77,790 0 22,468
Common stock issuance upon close of acquisition (see Note 2) 47,607 0 3,008
Notes payable increase through asset acquisition 0 7,164 0
Net assets of deconsolidated entities 0 73,042 0
Conversion of redeemable non-controlling interest to loan receivable $ 1,299 $ 0 $ 0